The local GI argument is the strongest case for capsules, but it is rarely explained correctly If BPC-157 is degraded locally in the gut lumen and acts on GI epithelial receptors before degradation, then high oral bioavailability is not required for a GI-local effect
However, no formal research examines this specific application
Why Choose OMNI SCULPT MD in Dallas for Peptide Therapy
Transneuronal propagation of pathologic -synuclein from the gut to the brain models parkinsons disease
BPC-157 for athletes and injury treatment: Science, safety, and legal concerns Maryke Louw Feb 17, 2025 5 min read Updated: Oct 3, 2025 BPC-157 is often marketed as a game-changing peptide for muscle repair, injury recovery, and athletic performance
This would require sending samples to laboratories equipped for mass spectrometry analysis